Literature DB >> 12941822

Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.

Callinice D Capo-chichi1, Isabelle H Roland, Lisa Vanderveer, Rudi Bao, Tetsuya Yamagata, Hisamaru Hirai, Cynthia Cohen, Thomas C Hamilton, Andrew K Godwin, Xiang-Xi Xu.   

Abstract

Tumor cells often appear in a deviant differentiated stage, and dedifferentiation is a hallmark of malignancy; however, the causative mechanism of the global changes in dedifferentiation is not understood. The GATA transcription factors function in cell lineage specification during embryonic development and organ formation. The transcriptional targets of the GATA factors in early embryonic development include Disabled-2 and collagen IV, markers for epithelial lineages. GATA-4 and GATA-6 are expressed strongly and are localized in the nucleus in ovarian surface epithelial cells in tissues or primary cell cultures. By immunohistochemistry, we found that 82% of the 50 tumors analyzed had lost GATA-6 function, either by a complete absence of expression or by cytoplasmic mislocalization. The frequent loss of GATA-6 was also confirmed in a panel of ovarian surface epithelial and tumor cell lines. Although GATA-4 is absent only in a small percentage (14%) of ovarian tumors, it is lost in the majority of established cell lines in culture. The loss of GATA-6 correlates with the loss of Disabled-2, collagen IV, and laminin, markers for epithelial cell types. Loss of GATA factors was also found in an in vitro model for spontaneous transformation of rat ovarian epithelial cells. Repression of GATA-6 by small interfering (si)RNA approach in cultured cells leads to dedifferentiation as indicated by the loss of Disabled-2 and laminin expression. Restoration of GATA factors expression by ectopic transfection suppresses cell growth and is incompatible with the maintenance of the cells in culture. However, restoration of GATA-4 and GATA-6 expression is not able to induce expression of endogenous Disabled-2 in tumor cells, suggesting that the loss of GATA factors and dedifferentiation are irreversible processes. In conclusion, we observed the inappropriate expression and cellular localization of the GATA transcription factors in ovarian tumor tissues and cancer cell lines, and we have demonstrated that down-regulation of GATA factor expression leads to dedifferentiation. We propose that alterations of GATA transcription factor expression and aberrant nucleocytoplasmic localization may contribute to the anomalous epithelial dedifferentiation of the ovarian tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941822

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Authors:  Narasimhaswamy S Belaguli; Muhammad Aftab; Mohammed Rigi; Mao Zhang; Daniel Albo; David H Berger
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Epithelial lineages of the small intestine have unique patterns of GATA expression.

Authors:  Mary R Dusing; Dan A Wiginton
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

3.  Trapping the mouse genome to hunt human alterations.

Authors:  Anne-Marie Bleau; Eric C Holland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-03       Impact factor: 11.205

Review 4.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

Review 5.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

6.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

Authors:  Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Daniel J Weisenberger; Hui Shen; Mihaela Campan; Houtan Noushmehr; Christopher G Bell; A Peter Maxwell; David A Savage; Elisabeth Mueller-Holzner; Christian Marth; Gabrijela Kocjan; Simon A Gayther; Allison Jones; Stephan Beck; Wolfgang Wagner; Peter W Laird; Ian J Jacobs; Martin Widschwendter
Journal:  Genome Res       Date:  2010-03-10       Impact factor: 9.043

7.  Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models.

Authors:  Callinice D Capo-chichi; Toni M Yeasky; Joshua F Heiber; Ying Wang; Glen N Barber; Xiang-Xi Xu
Journal:  Gynecol Oncol       Date:  2009-11-22       Impact factor: 5.482

8.  GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts.

Authors:  Angela Ghatnekar; Maria Trojanowska
Journal:  Biochim Biophys Acta       Date:  2007-12-14

9.  GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.

Authors:  Deepak Kamnasaran; Baoping Qian; Cynthia Hawkins; William L Stanford; Abhijit Guha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

10.  Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.

Authors:  Kathy Qi Cai; Corrado Caslini; Callinice D Capo-chichi; Carolyn Slater; Elizabeth R Smith; Hong Wu; Andres J Klein-Szanto; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.